Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

NCT05055167 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer Stage IV

Interventions

DRUG: Envafolimab

Sponsor

The First Affiliated Hospital of Xiamen University